JP2019504877A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504877A5 JP2019504877A5 JP2018553042A JP2018553042A JP2019504877A5 JP 2019504877 A5 JP2019504877 A5 JP 2019504877A5 JP 2018553042 A JP2018553042 A JP 2018553042A JP 2018553042 A JP2018553042 A JP 2018553042A JP 2019504877 A5 JP2019504877 A5 JP 2019504877A5
- Authority
- JP
- Japan
- Prior art keywords
- particles
- composition
- carrier
- antigens
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022125126A JP7586863B2 (ja) | 2015-12-23 | 2022-08-04 | 共有ポリマー抗原コンジュゲート化粒子 |
| JP2024195011A JP2025060584A (ja) | 2015-12-23 | 2024-11-07 | 共有ポリマー抗原コンジュゲート化粒子 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562387183P | 2015-12-23 | 2015-12-23 | |
| US62/387,183 | 2015-12-23 | ||
| US201662292098P | 2016-02-05 | 2016-02-05 | |
| US62/292,098 | 2016-02-05 | ||
| PCT/US2016/068423 WO2017112899A1 (en) | 2015-12-23 | 2016-12-22 | Covalent polymer-antigen conjugated particles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022125126A Division JP7586863B2 (ja) | 2015-12-23 | 2022-08-04 | 共有ポリマー抗原コンジュゲート化粒子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019504877A JP2019504877A (ja) | 2019-02-21 |
| JP2019504877A5 true JP2019504877A5 (enExample) | 2020-02-06 |
| JP7194593B2 JP7194593B2 (ja) | 2022-12-22 |
Family
ID=59091248
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018553042A Active JP7194593B2 (ja) | 2015-12-23 | 2016-12-22 | 共有ポリマー抗原コンジュゲート化粒子 |
| JP2022125126A Active JP7586863B2 (ja) | 2015-12-23 | 2022-08-04 | 共有ポリマー抗原コンジュゲート化粒子 |
| JP2024195011A Pending JP2025060584A (ja) | 2015-12-23 | 2024-11-07 | 共有ポリマー抗原コンジュゲート化粒子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022125126A Active JP7586863B2 (ja) | 2015-12-23 | 2022-08-04 | 共有ポリマー抗原コンジュゲート化粒子 |
| JP2024195011A Pending JP2025060584A (ja) | 2015-12-23 | 2024-11-07 | 共有ポリマー抗原コンジュゲート化粒子 |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US11510996B2 (enExample) |
| EP (1) | EP3393514A4 (enExample) |
| JP (3) | JP7194593B2 (enExample) |
| KR (1) | KR102822161B1 (enExample) |
| AU (1) | AU2016379413B2 (enExample) |
| CA (1) | CA3008892A1 (enExample) |
| IL (1) | IL260074B2 (enExample) |
| WO (1) | WO2017112899A1 (enExample) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9517257B2 (en) | 2010-08-10 | 2016-12-13 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| AU2011289579B2 (en) | 2010-08-10 | 2016-11-17 | Ecole Polytechnique Federale De Lausanne | Erythrocyte-binding therapeutics |
| US9850296B2 (en) | 2010-08-10 | 2017-12-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Erythrocyte-binding therapeutics |
| WO2013163176A1 (en) | 2012-04-23 | 2013-10-31 | Allertein Therapeutics, Llc | Nanoparticles for treatment of allergy |
| CA2907915C (en) | 2013-04-03 | 2023-03-07 | Allertein Therapeutics, Llc | Immunomodulatory nanoparticle compositions comprising a plurality of nanoparticles comprising biodegradable or biocompatible polymers and hydrophilic and hydrophobic cellular components |
| CA2946064C (en) | 2014-02-21 | 2023-09-26 | Ecole Polytechnique Federale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10946079B2 (en) | 2014-02-21 | 2021-03-16 | Ecole Polytechnique Federale De Lausanne | Glycotargeting therapeutics |
| US10953101B2 (en) | 2014-02-21 | 2021-03-23 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| US10046056B2 (en) | 2014-02-21 | 2018-08-14 | École Polytechnique Fédérale De Lausanne (Epfl) | Glycotargeting therapeutics |
| JP7194593B2 (ja) * | 2015-12-23 | 2022-12-22 | クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド | 共有ポリマー抗原コンジュゲート化粒子 |
| EP3638296A1 (en) | 2017-06-16 | 2020-04-22 | The University Of Chicago | Compositions and methods for inducing immune tolerance |
| EP4215186A1 (en) * | 2018-02-08 | 2023-07-26 | Cour Pharmaceuticals Development Company Inc. | Treatment of celiac disease with tolerizing particles |
| EP3790577A4 (en) | 2018-05-09 | 2022-04-27 | The University of Chicago | COMPOSITIONS AND METHODS RELATED TO IMMUNTOLERANCE |
| EP3814272A4 (en) * | 2018-05-11 | 2022-03-02 | Phosphorex, Inc. | Microparticles and nanoparticles having negative surface charges |
| WO2020037174A1 (en) | 2018-08-16 | 2020-02-20 | The Johns Hopkins University | Antibodies to human znt8 |
| KR20220054305A (ko) * | 2019-07-31 | 2022-05-02 | 온코어 파마, 인크. | 면역 회피성 종양의 치료 |
| GB201913408D0 (en) * | 2019-09-17 | 2019-10-30 | King S College London | Proinsulin peptides for type 1 diabetes |
| US12366570B2 (en) | 2019-10-01 | 2025-07-22 | The Johns Hopkins University | Cell-based ZNT8 assay |
| WO2022032290A2 (en) * | 2020-08-05 | 2022-02-10 | University Of Maryland, Baltimore | Engineering diverse antigen-presenting cells to control antigen-specific responses |
| CN112057425A (zh) * | 2020-09-30 | 2020-12-11 | 严鹏科 | 一种雷帕霉素制剂及其制备方法 |
| AU2022256497A1 (en) * | 2021-04-16 | 2023-11-30 | Cour Pharmaceuticals Development Company Inc. | Treatment of peanut allergy with tolerizing nanoparticles |
| IL307722A (en) | 2021-04-16 | 2023-12-01 | Cour Pharmaceuticals Dev Company Inc | A method of monitoring the existence of immunological tolerance |
| WO2023070104A1 (en) | 2021-10-21 | 2023-04-27 | Cour Pharmaceuticals Development Company Inc. | Treatment of primary biliary cholangitis (pbc) with tolerizing nanoparticles |
| TW202400801A (zh) * | 2022-04-29 | 2024-01-01 | 美商庫爾製藥發展公司股份有限公司 | 用於克服治療性載體及蛋白質之免疫原性之耐受性免疫修飾奈米粒子 |
| WO2024026452A1 (en) | 2022-07-29 | 2024-02-01 | Repertoire Immune Medicines, Inc. | T cell epitopes associated with type 1 diabetes |
| WO2024086706A1 (en) | 2022-10-19 | 2024-04-25 | Cour Pharmaceuticals Development Company Inc. | Treatment of peanut allergy with tolerizing nanoparticles |
| WO2024206202A1 (en) * | 2023-03-24 | 2024-10-03 | Cour Pharmaceuticals Development Company Inc. | Tolerizing immune modifying nanoparticles for myasthenia gravis treatment |
| KR20260016937A (ko) | 2023-05-23 | 2026-02-04 | 코어 파마슈티칼스 디벨롭먼트 컴퍼니 인크. | 원발성 담즙성 담관염의 치료를 위한 관용화 나노입자의 제조 |
| TW202500576A (zh) | 2023-05-25 | 2025-01-01 | 美商庫爾製藥發展公司股份有限公司 | 以免疫耐受性(tolerizing)奈米粒子治療1型糖尿病(t1d) |
| WO2025072849A1 (en) | 2023-09-29 | 2025-04-03 | Repertoire Immune Medicines, Inc. | Mhc-presentable peptides associated with type 1 diabetes |
| WO2025199149A1 (en) * | 2024-03-18 | 2025-09-25 | Cour Pharmaceuticals Development Company Inc. | Sting agonism for antigen specific tolerance |
| WO2026015713A1 (en) * | 2024-07-10 | 2026-01-15 | The Regents Of The University Of Michigan | Tolerizing immune modifying nanoparticles for treatment of alpha gal syndrome |
| WO2026019942A2 (en) | 2024-07-16 | 2026-01-22 | Cour Pharmaceuticals Development Company Inc. | Tolerizing immune modifying nanoparticles for treatment of narcolepsy |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| BR9306042A (pt) | 1992-02-28 | 1997-11-18 | Autoimmune Inc | Método para tratar uma doença auto-immune em um mamifero e formas de dosagens farmacêuticas oral e inalável |
| AU674584B2 (en) | 1993-06-02 | 1997-01-02 | Tvw Telethon Institute For Child Health Research | Cryptic peptides for use in inducing immunologic tolerance |
| DE69818052T2 (de) | 1997-03-31 | 2004-07-08 | The Regents Of The University Of Michigan, Ann Arbor | Offenporige bioabbaubare matrize |
| US7427602B1 (en) | 1998-05-13 | 2008-09-23 | The Regents Of The University Of Michigan | Sustained DNA delivery from structural matrices |
| US7029697B2 (en) | 2001-02-14 | 2006-04-18 | Northwestern University | Controlled surface-associated delivery of genes and oligonucleotides |
| US6890556B1 (en) | 2001-02-14 | 2005-05-10 | Northwestern University | Controlled surface-associated delivery of genes and oligonucleotides |
| US8198020B2 (en) | 2003-08-22 | 2012-06-12 | Potentia Pharmaceuticals, Inc. | Compositions and methods for enhancing phagocytosis or phagocyte activity |
| US7846466B2 (en) | 2004-06-10 | 2010-12-07 | Northwestern University | Biodegradable scaffolds and uses thereof |
| WO2006082204A1 (en) | 2005-02-02 | 2006-08-10 | Novo Nordisk A/S | Insulin derivatives |
| MX2010003642A (es) * | 2007-10-12 | 2010-08-09 | Massachusetts Inst Technology | Nanotecnologia de vacuna. |
| US20090238879A1 (en) | 2008-01-24 | 2009-09-24 | Northwestern University | Delivery scaffolds and related methods of use |
| US8343498B2 (en) * | 2008-10-12 | 2013-01-01 | Massachusetts Institute Of Technology | Adjuvant incorporation in immunonanotherapeutics |
| EP3269379A1 (en) | 2008-11-30 | 2018-01-17 | Immusant, Inc. | Compositions and methods for treatment of celiac disease |
| MX2011007559A (es) | 2009-01-20 | 2011-12-06 | Myelin Repair Foundation Inc | Composiciones y metodos para induccion de tolerancia antigeno-especifica. |
| KR102283760B1 (ko) * | 2012-06-21 | 2021-08-03 | 노쓰웨스턴유니버시티 | 펩티드 접합된 입자 |
| DK3033102T4 (da) | 2013-08-13 | 2024-02-26 | Univ Northwestern | Peptidkonjugerede partikler |
| JP7194593B2 (ja) * | 2015-12-23 | 2022-12-22 | クール ファーマシューティカルズ ディベロップメント カンパニー インコーポレイテッド | 共有ポリマー抗原コンジュゲート化粒子 |
-
2016
- 2016-12-22 JP JP2018553042A patent/JP7194593B2/ja active Active
- 2016-12-22 KR KR1020187020952A patent/KR102822161B1/ko active Active
- 2016-12-22 IL IL260074A patent/IL260074B2/en unknown
- 2016-12-22 AU AU2016379413A patent/AU2016379413B2/en active Active
- 2016-12-22 EP EP16880118.1A patent/EP3393514A4/en active Pending
- 2016-12-22 WO PCT/US2016/068423 patent/WO2017112899A1/en not_active Ceased
- 2016-12-22 US US16/064,528 patent/US11510996B2/en active Active
- 2016-12-22 CA CA3008892A patent/CA3008892A1/en active Pending
-
2022
- 2022-08-04 JP JP2022125126A patent/JP7586863B2/ja active Active
- 2022-10-24 US US18/049,136 patent/US12502436B2/en active Active
-
2024
- 2024-11-07 JP JP2024195011A patent/JP2025060584A/ja active Pending
-
2025
- 2025-10-24 US US19/368,710 patent/US20260144891A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Drachuk et al. | pH-responsive layer-by-layer nanoshells for direct regulation of cell activity | |
| Mauri et al. | Nanogel functionalization: a versatile approach to meet the challenges of drug and gene delivery | |
| Bagre et al. | Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment | |
| Schubert et al. | Coating matters: Review on colloidal stability of nanoparticles with biocompatible coatings in biological media, living cells and organisms | |
| Li et al. | Core–shell supramolecular gelatin nanoparticles for adaptive and “on-demand” antibiotic delivery | |
| Gattás-Asfura et al. | Bioorthogonal layer-by-layer encapsulation of pancreatic islets via hyperbranched polymers | |
| Wang et al. | More effective nanomedicines through particle design | |
| Wong et al. | Modulating antimicrobial activity and mammalian cell biocompatibility with glucosamine-functionalized star polymers | |
| Park et al. | Lipid-hydrogel-nanostructure hybrids as robust biofilm-resistant polymeric materials | |
| Tang et al. | Physical hydrogels with self-assembled nanostructures as drug delivery systems | |
| Luc et al. | Antifouling properties of amine-oxide-containing zwitterionic polymers | |
| MX350501B (es) | Nanotecnologia de vacuna. | |
| JP2011520813A5 (enExample) | ||
| CN105327353B (zh) | 一种模拟超氧化物歧化酶/过氧化氢酶的纳米药物、制备方法及其应用 | |
| Laaser et al. | Interpolyelectrolyte complexes of polycationic micelles and linear polyanions: Structural stability and temporal evolution | |
| JP2017520567A (ja) | 可溶性生物製剤、治療薬およびイメージング剤をカプセル化するためのプロセス | |
| Richardson et al. | Thermally induced charge reversal of layer-by-layer assembled single-component polymer films | |
| JP2018503736A5 (enExample) | ||
| Hu et al. | Preparation and properties of Janus heparin-loaded ammoniated-hollow mesoporous silica nanomotors | |
| Vorobii et al. | Antifouling microparticles to scavenge lipopolysaccharide from human blood plasma | |
| US8586095B2 (en) | Thermosensitive nanostructure for hyperthermia treatment | |
| Thalhauser et al. | Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery | |
| Chen et al. | Broad-spectrum clearance of lipopolysaccharides from blood based on a hemocompatible dihistidine polymer | |
| Raghavan et al. | Physicochemical design of nanoparticles to interface with and degrade neutrophil extracellular traps | |
| Saraei et al. | Co‐delivery of methotrexate and doxorubicin via nanocarriers of star‐like poly (DMAEMA‐block‐HEMA‐block‐AAc) terpolymers |